Home » Topics » BioWorld Science

BioWorld Science
RSS

Prevail Therapeutics advances development of PR-001 for Parkinson's and Gaucher's diseases

Sep. 12, 2019

Adverum reports 24-week cohort 1 data from phase I study of ADVM-022 in wet AMD

Sep. 12, 2019

Tubulis enters collaboration with Glycotope for development of novel ADC therapy

Sep. 12, 2019

Ocrelizumab in RRMS: CASTING study phase III results presented

Sep. 12, 2019

Glioblastoma stem cells co-opt circadian pacemakers

Sep. 12, 2019

Oryzon Genomics presents preliminary phase II data on iadademstat in SCLC

Sep. 12, 2019

FDA approves Xeris' Gvoke, first ready-to-use stable liquid glucagon for severe hypoglycemia

Sep. 12, 2019

P53 upregulation predicts malaria immunity in children

Sep. 12, 2019

Phio Pharmaceuticals enters agreement with Carisma Therapeutics to enhance adoptive cell therapy

Sep. 12, 2019

KAHR Medical, Roche trial collaboration to test DSP-107/atezolizumab in lung cancer

Sep. 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...